In summary, this study identifies ERN1 and SLC11A1 as characteristic IM-FT-related biomarkers, which are significantly differentially expressed in NAFLD and exhibit strong diagnostic performance. This evidence concerns the gene ERN1 and metabolic dysfunction-associated steatotic liver disease.